Q & M Dental Group (Singapore) Limited (SG:QC7) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Q & M Dental Group’s subsidiary, Acumen Diagnostics, faces a setback as its clinical laboratory service licence will expire on September 15, 2024, due to unsuccessful attempts to transfer the licence from Dr. Ong Siew Hwa to the company. Acumen has halted related operations and is contemplating applying for a new licence. The impact of this change on the Group’s financial performance for the year is under review, with further updates to be provided to shareholders.
For further insights into SG:QC7 stock, check out TipRanks’ Stock Analysis page.